The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients.

NCT04450953 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation for More Than One Year
Patients with a Kidney Transplantation on Cyclosporine

Interventions

DRUG: Eplerenone 50mg/day (cross over design)
OTHER: Period without eplerenone (cross over design)

Sponsor

Central Hospital, Nancy, France